Your browser doesn't support javascript.
loading
Development of "on-demand" thermo-responsive hydrogels for anti-cancer drugs sustained release: Rational design, in silico prediction and in vitro validation in colon cancer models.
Carreño, Gustavo; Pereira, Alfredo; Ávila-Salas, Fabián; Marican, Adolfo; Andrade, Fernanda; Roca-Melendres, Maria Mercé; Valdés, Oscar; Vijayakumar, Sekar; Schwartz, Simó; Abasolo, Ibane; Rafael, Diana; Durán-Lara, Esteban F.
Afiliação
  • Carreño G; Bio and NanoMaterials Lab, Drug Delivery and Controlled Release, Universidad de Talca, Talca, Maule, Chile; Instituto de Química de Recursos Naturales, Universidad de Talca, Talca, Maule, Chile.
  • Pereira A; Instituto de Química de Recursos Naturales, Universidad de Talca, Talca, Maule, Chile.
  • Ávila-Salas F; Centro de Nanotecnología Aplicada, Facultad de Ciencias, Universidad Mayor, Huechuraba 8580000, Región Metropolitana, Chile.
  • Marican A; Bio and NanoMaterials Lab, Drug Delivery and Controlled Release, Universidad de Talca, Talca, Maule, Chile; Instituto de Química de Recursos Naturales, Universidad de Talca, Talca, Maule, Chile.
  • Andrade F; Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine), Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; School of Pharmacy, Barcelona University, Barcelona, Spain.
  • Roca-Melendres MM; Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine), Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Valdés O; Centro de Investigación de Estudios Avanzados del Maule (CIEAM), Vicerrectoría de Investigación y Postgrado, Universidad Católica del Maule, Talca 3460000, Maule, Chile.
  • Vijayakumar S; Marine College, Shandong University, Weihai 264209, PR China.
  • Schwartz S; Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine), Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; Networking Research Centre for Bioengineering, Biomaterials, and Nanomedicine (CIBER-B
  • Abasolo I; Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine), Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; Networking Research Centre for Bioengineering, Biomaterials, and Nanomedicine (CIBER-B
  • Rafael D; Drug Delivery and Targeting Group, Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine), Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; Networking Research Centre for Bioengineering, Biomaterials, and Nanomedicine (CIBER-B
  • Durán-Lara EF; Bio and NanoMaterials Lab, Drug Delivery and Controlled Release, Universidad de Talca, Talca, Maule, Chile; Departamento de Microbiología, Facultad de Ciencias de la Salud, Universidad de Talca, Talca, Maule, Chile. Electronic address: eduran@utalca.cl.
Mater Sci Eng C Mater Biol Appl ; 131: 112483, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34857269
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Chile
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Chile